Home » News / Press Releases
SynapCell Reaches a Major Milestone in 2026: From Advanced Anti-Epileptic Screening to Sovereign AI-Powered Drug Discovery The year 2026 marks a turning point for SynapCell. Building on its recognized expertise in translational electrophysiology, the company...
SynapCell and the University of Utah Celebrate their 10 Year Anniversary of Collaboration on AntiSeizure Medications Grenoble, France / Salt Lake City, UT, USA, June 6, 2024 – SynapCell celebrates today the ten-year anniversary of...
SynapCell and Reservoir Neuroscience Announce Collaboration for Development of Treatment for Chronic Epilepsy Saint-Ismier, FRANCE, and Emeryville, CA, USA, Dec. 15th, 2021 – SynapCell, a company providing advanced predictive models for evaluating the efficacy of...
SynapCell and Motac Neuroscience Discover New Biomarker of Parkinson’s Disease Progression Chicago, IL – Oct 21, 2019 – SynapCell and Motac Neuroscience have discovered a new biomarker for progression of Parkinson’s Disease (PD). The BetaPark...
SynapCell Re-establishes Partnership with the University of Utah to Screen Novel Antiepileptic Medications The University of Utah has awarded a subcontract to SynapCell as part of the NIH/NINDS Epilepsy Therapy Screening Program (ETSP). The partnership...